All Stories

  1. Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study

    Article • European Neuropsychopharmacology, March 2026, Elsevier

    Dr Marco Colizzi

  2. Effect of Specialized Psychiatric Assessment and Precision Diagnosis on Pharmacotherapy in Adults with Intellectual Disability

    Article • Journal of Clinical Medicine, January 2026, MDPI AG

    Dr Marco Colizzi

  3. Eating Disorders and Autistic Traits Camouflaging: Insights from the EAT Study

    Article • Nutrients, December 2025, MDPI AG

    Dr Marco Colizzi

  4. Effect of Specialized Psychiatric Assessment and Precision Diagnosis On Pharmacotherapy in Adults with Intellectual Disability

    Article • December 2025, MDPI AG

    Dr Marco Colizzi

  5. Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial

    Article • Brain Behavior & Immunity - Health, December 2025, Elsevier

    Dr Marco Colizzi

  6. Mental health prevention: moving forward with the evidence

    Article • Discover Mental Health, November 2025, Springer Science + Business Media

    Dr Marco Colizzi

  7. Revisiting Franco Basaglia’s legacy: theoretical and clinical implications for modern psychiatry: commentary, Colizzi

    Article • The British Journal of Psychiatry, November 2025, Royal College of Psychiatrists

    Dr Marco Colizzi

  8. Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms

    Article • American Journal on Addictions, October 2025, Wiley

    Dr Marco Colizzi

  9. Examining psychological protective mechanisms as moderators of the association between autistic traits and psychosis expression in a general population twin sample

    Article • Schizophrenia Research, October 2025, Elsevier

    Dr Marco Colizzi

  10. Maternal vulnerability to insomnia: Relationship with poor newborn sleep and peripartum psychopathology

    Article • Sleep Medicine, October 2025, Elsevier

    Dr Marco Colizzi

  11. Ten priorities that are shaping the future of mental health prevention

    Article • Discover Mental Health, September 2025, Springer Science + Business Media

    Dr Marco Colizzi

  12. Trends in suicide attempts and deaths in Northeast Italy (2014 to 2023): A rising burden among young women

    Article • Psychiatry Research, September 2025, Elsevier

    Dr Marco Colizzi

  13. Defining the Scientist: A Consensus-Based Approach

    Article • Barw Medical Journal, June 2025, Barw Medical Journal

    Dr Marco Colizzi

  14. Psychological interventions tailored to the needs of individuals with hearing and visual impairments: What do we know and what should we do? A commentary on “A systematic review and meta-analysis of psychological interventions for persons with hearing ...

    Article • Clinical Psychology Science and Practice, June 2025, American Psychological Association (APA)

    alvisa palese, Dr Marco Colizzi

  15. Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study

    Article • Healthcare, March 2025, MDPI AG

    Dr Marco Colizzi

  16. Editorial: Case reports in autism: 2023

    Article • Frontiers in Psychiatry, February 2025, Frontiers

    Dr Marco Colizzi

  17. Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations

    Article • Brain Behavior & Immunity - Health, February 2025, Elsevier

    Dr Marco Colizzi

  18. In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages

    Article • Current Neuropharmacology, January 2025, Bentham Science Publishers

    Dr Marco Colizzi

  19. Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network a...

    Article • European Neuropsychopharmacology, January 2025, Elsevier

    Dr Marco Colizzi, Ching-Fang Sun, Prof Philip Ward

  20. The Moderating Role of Genetic and Environmental Risk Factors for Schizophrenia on the Relationship between Autistic Traits and Psychosis Expression in the General Population

    Article • Schizophrenia Bulletin Open, January 2025, Oxford University Press (OUP)

    Dr Marco Colizzi, marc de hert

  21. The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis

    Article • Brain Sciences, December 2024, MDPI AG

    Dr Marco Colizzi

  22. Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate “simplex” and “complex” phenotypes

    Article • BMC Psychiatry, December 2024, Springer Science + Business Media

    Dr Marco Colizzi

  23. Is a No-Restraint Policy Associated with Increased Aggression Towards Healthcare Professionals Among Inpatient Psychiatric Units? A 16-Year Retrospective Observational Study Conducted in Italy

    Article • Nursing Reports, December 2024, MDPI AG

    Dr Marco Colizzi

  24. Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study

    Article • Psychiatry Research, December 2024, Elsevier

    Ching-Fang Sun, Dr Marco Colizzi

  25. Challenges in addressing youth mental health

    Article • The Lancet Psychiatry, December 2024, Elsevier

    Dr Marco Colizzi

  26. Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 2024, Elsevier

    Dr Marco Colizzi, Prof Philip Ward

  27. Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire

    Article • Psychiatry International, October 2024, MDPI AG

    Dr Marco Colizzi

  28. Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases

    Article • Frontiers in Psychiatry, October 2024, Frontiers

    Dr Marco Colizzi

  29. Lessons Learnt From Running a Transition‐Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience

    Article • Early Intervention in Psychiatry, August 2024, Wiley

    Dr Marco Colizzi

  30. Cannabidiol (CBD) Listed as a Drug of Abuse by the Italian Health Ministry: Expert Opinion

    Article • Current Social Sciences, August 2024, Bentham Science Publishers

    Dr Marco Colizzi

  31. CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL)

    Article • Barw Medical Journal, June 2024, Barw Medical Journal

    Dr Marco Colizzi, Dr. Mahmoud Nassar

  32. The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults

    Article • Clinical and Translational Neuroscience, May 2024, MDPI AG

    Dr Marco Colizzi

  33. Prevalence and risk factors for depression in factitious disorder: a systematic review

    Article • Frontiers in Psychiatry, April 2024, Frontiers

    Dr Marco Colizzi

  34. Tic-Related Obsessive–Compulsive and Eating Disorders in Dandy–Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles

    Article • Brain Sciences, April 2024, MDPI AG

    Dr Marco Colizzi

  35. Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study

    Article • Journal of Sleep Research, March 2024, Wiley

    Dr Marco Colizzi

  36. COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes

    Article • Irish Journal of Psychological Medicine, February 2024, Cambridge University Press

    Dr Marco Colizzi

  37. Editorial: Case reports in autism

    Article • Frontiers in Psychiatry, January 2024, Frontiers

    Dr Marco Colizzi

  38. Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk

    Article • Journal of Affective Disorders Reports, January 2024, Elsevier

    Dr Marco Colizzi

  39. Impact of COVID-19 on behavior in autism spectrum disorder

    Article • January 2024, Elsevier

    Dr Marco Colizzi

  40. Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9‐year chart review study

    Article • Autism Research, November 2023, Wiley

    Dr Marco Colizzi

  41. Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years

    Article • Health Research Policy and Systems, October 2023, Springer Science + Business Media

    Dr Marco Colizzi

  42. Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy

    Article • Frontiers in Psychiatry, October 2023, Frontiers

    Dr Marco Colizzi

  43. Editorial: Advances in understanding the pathogenetic mechanisms of neurodevelopmental disorders and neurodegenerative disease — The environment as a putative risk factor

    Article • Frontiers in Neurology, August 2023, Frontiers

    Dr Marco Colizzi

  44. Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review

    Article • Current Neuropharmacology, August 2023, Bentham Science Publishers

    Dr Marco Colizzi

  45. Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

    Article • Frontiers in Psychiatry, July 2023, Frontiers

    Dr Marco Colizzi

  46. COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection

    Article • Brain Sciences, July 2023, MDPI AG

    Dr Marco Colizzi

  47. Editorial: Developmental trajectories in mental health between adolescence and adulthood

    Article • Frontiers in Psychiatry, June 2023, Frontiers

    Dr Marco Colizzi

  48. Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study

    Article • Psychiatry Research Communications, June 2023, Elsevier

    Dr Marco Colizzi

  49. Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UK

    Article • The Lancet Psychiatry, June 2023, Elsevier

    Dr Marco Colizzi

  50. Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management

    Article • Addictive Behaviors Reports, June 2023, Elsevier

    Dr Marco Colizzi

  51. Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study

    Article • Journal of Clinical Medicine, April 2023, MDPI AG

    Dr Marco Colizzi

  52. Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood

    Article • Healthcare, April 2023, MDPI AG

    Dr Marco Colizzi

  53. Association between stressful life events and psychosis relapse: a 2‐year prospective study in first‐episode psychosis

    Article • World Psychiatry, January 2023, Wiley

    Dr Marco Colizzi

  54. Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study

    Article • International Journal of Environmental Research and Public Health, January 2023, MDPI AG

    Dr Marco Colizzi

  55. Prevalence and Risk Factors for Absconding from an Open-Door, No-Restraint Inpatient Psychiatric Unit: A Single-Center Study in Italy

    Article • Behavioral Sciences, January 2023, MDPI AG

    Dr Marco Colizzi

  56. Uncovering Mental Health Insights: Exploring Cannabis and Psychosis Link in the UK

    Article • Epidemiology and Psychiatric Sciences, January 2023, Cambridge University Press

    Dr Marco Colizzi

  57. Editorial: Methods and applications in addiction psychiatry research: 2021

    Article • Frontiers in Psychiatry, December 2022, Frontiers

    Dr Marco Colizzi

  58. Development and Reliability of a Questionnaire Assessing Stress, Coping, and Empathy (SCOPE) in Occupational Settings: Preliminary Evidence from Veterinarians

    Article • Psychiatry International, December 2022, MDPI AG

    Dr Marco Colizzi

  59. Validation of the collaborative outcomes study on health and functioning during infection times (COH-FIT) questionnaire for adults

    Article • Journal of Affective Disorders, December 2022, Elsevier

    Dr Marco Colizzi, Prof Philip Ward, Professor Jari Tiihonen

  60. Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence

    Article • Frontiers in Psychiatry, October 2022, Frontiers

    Dr Marco Colizzi

  61. Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder?

    Article • Current Psychiatry Research and Reviews, August 2022, Bentham Science Publishers

    Dr Marco Colizzi

  62. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

    Article • Healthcare, August 2022, MDPI AG

    Dr Marco Colizzi

  63. Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors

    Article • Revista de Psiquiatría y Salud Mental, June 2022, Elsevier

    Dr Marco Colizzi

  64. The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System

    Article • International Journal of Environmental Research and Public Health, May 2022, MDPI AG

    Dr Marco Colizzi

  65. Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021

    Article • Psychiatry Research Communications, March 2022, Elsevier

    Dr Marco Colizzi

  66. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

    Article • Journal of Affective Disorders, February 2022, Elsevier

    Dr Marco Colizzi, Ching-Fang Sun, Prof Philip Ward

  67. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

    Article • Journal of Affective Disorders, February 2022, Elsevier

    Dr Marco Colizzi, Ching-Fang Sun, Prof Philip Ward, Professor Jari Tiihonen

  68. Gender-Oriented Mental Health Prevention: A Reappraisal

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Dr Marco Colizzi

  69. Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

    Article • Brain Sciences, January 2022, MDPI AG

    Dr Marco Colizzi

  70. Neurodevelopmental Disorders and Psychosocial Issues Later in Life

    Article • January 2022, Springer Science + Business Media

    Dr Marco Colizzi

  71. Prevention in Mental Health

    Article • January 2022, Springer Science + Business Media

    Dr Marco Colizzi

  72. Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation

    Article • Journal of Affective Disorders Reports, December 2021, Elsevier

    Dr Marco Colizzi

  73. Additional Evidence for Neuropsychiatric Manifestations in Mosaic Trisomy 20: A Case Report and Brief Review

    Article • Children, November 2021, MDPI AG

    Dr Marco Colizzi

  74. Meet the Editorial Board Member

    Article • Current Psychiatry Research and Reviews, November 2021, Bentham Science Publishers

    Dr Marco Colizzi

  75. Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry

    Article • Frontiers in Psychiatry, October 2021, Frontiers

    Dr Marco Colizzi

  76. 21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, October 2021, Elsevier

    Dr Marco Colizzi

  77. Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases

    Article • Reports — Medical Cases Images and Videos, September 2021, MDPI AG

    Dr Marco Colizzi

  78. Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

    Article • Brain Sciences, September 2021, MDPI AG

    Dr Marco Colizzi

  79. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence

    Article • Nutrients, April 2021, MDPI AG

    Dr Marco Colizzi

  80. Effectiveness of Equine-Assisted Activities and Therapies for Improving Adaptive Behavior and Motor Function in Autism Spectrum Disorder

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Dr Marco Colizzi

  81. Postural Control in Childhood: Investigating the Neurodevelopmental Gradient Hypothesis

    Article • International Journal of Environmental Research and Public Health, February 2021, MDPI AG

    Dr Marco Colizzi

  82. The Effectiveness of Lurasidone Add-On for Residual Aggressive Behavior and Obsessive Symptoms in Antipsychotic-Treated Children and Adolescents with Tourette Syndrome: Preliminary Evidence from a Case Series

    Article • Children, February 2021, MDPI AG

    Dr Marco Colizzi

  83. Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior

    Article • Brain Sciences, November 2020, MDPI AG

    Dr Marco Colizzi

  84. Adolescent Lifestyle Behaviors, Coping Strategies and Subjective Wellbeing during the COVID-19 Pandemic: An Online Student Survey

    Article • Healthcare, November 2020, MDPI AG

    Dr Marco Colizzi

  85. Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol

    Article • Psychological Medicine, October 2020, Cambridge University Press

    Dr Marco Colizzi

  86. 4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, October 2020, Elsevier

    Dr Marco Colizzi

  87. 51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, October 2020, Elsevier

    Dr Marco Colizzi

  88. Investigating Gait, Movement, and Coordination in Children with Neurodevelopmental Disorders: Is There a Role for Motor Abnormalities in Atypical Neurodevelopment?

    Article • Brain Sciences, September 2020, MDPI AG

    Dr Marco Colizzi

  89. Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence

    Article • Frontiers in Psychiatry, August 2020, Frontiers

    Dr Marco Colizzi

  90. Psychosocial and Behavioral Impact of COVID-19 in Autism Spectrum Disorder: An Online Parent Survey

    Article • Brain Sciences, June 2020, MDPI AG

    Dr Marco Colizzi

  91. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

    Article • Frontiers in Psychology, May 2020, Frontiers

    Dr Marco Colizzi

  92. Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report

    Article • Brain Behavior & Immunity - Health, May 2020, Elsevier

    Dr Marco Colizzi

  93. Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis

    Article • Translational Psychiatry, April 2020, Springer Science + Business Media

    Dr Marco Colizzi

  94. Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care?

    Article • International Journal of Mental Health Systems, March 2020, Springer Science + Business Media

    Dr Marco Colizzi

  95. Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship

    Article • Brain Sciences, February 2020, MDPI AG

    Dr Marco Colizzi

  96. Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review

    Article • Psychological Medicine, February 2020, Cambridge University Press

    Dr Marco Colizzi

  97. The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study

    Article • Schizophrenia Research, February 2020, Elsevier

    Dr Marco Colizzi

  98. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends

    Article • Psychiatry Research, February 2020, Elsevier

    Dr Marco Colizzi, Tina Dam Kristensen

  99. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis

    Article • Psychological Medicine, January 2020, Cambridge University Press

    Dr Marco Colizzi

  100. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis

    Article • Psychopharmacology, January 2020, Springer Science + Business Media

    Dr Marco Colizzi

  101. Is there sufficient evidence that cannabis use is a risk factor for psychosis?

    Article • January 2020, Elsevier

    Dr Marco Colizzi

  102. Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach

    Article • RIVISTA SPERIMENTALE DI FRENIATRIA, November 2019, Franco Angeli

    Dr Marco Colizzi

  103. Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids

    Article • Psychological Medicine, August 2019, Cambridge University Press

    Dr Marco Colizzi

  104. Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study

    Article • The British Journal of Psychiatry, July 2019, Royal College of Psychiatrists

    Dr Marco Colizzi

  105. Differential gene expression analysis in blood of first episode psychosis patients

    Article • Schizophrenia Research, May 2019, Elsevier

    Dr Marco Colizzi

  106. Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans

    Article • Brain Sciences, April 2019, MDPI AG

    Dr Marco Colizzi

  107. O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM?

    Article • Schizophrenia Bulletin, April 2019, Oxford University Press (OUP)

    Dr Marco Colizzi

  108. Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis

    Article • Schizophrenia Research, March 2019, Elsevier

    Dr Marco Colizzi

  109. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

    Article • Molecular Psychiatry, February 2019, Springer Science + Business Media

    Dr Marco Colizzi

  110. The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review

    Article • Current Addiction Reports, January 2019, Springer Science + Business Media

    Dr Marco Colizzi

  111. Correction to: The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task

    Article • Neuropsychology Review, December 2018, Springer Science + Business Media

    Dr Marco Colizzi

  112. Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study

    Article • Psychological Medicine, November 2018, Cambridge University Press

    Victoria Rodriguez, Dr Marco Colizzi

  113. Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort

    Article • Psychiatry Research, October 2018, Elsevier

    Dr Marco Colizzi

  114. Cannabis use and the development of tolerance: a systematic review of human evidence

    Article • Neuroscience & Biobehavioral Reviews, October 2018, Elsevier

    Dr Marco Colizzi

  115. The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task

    Article • Neuropsychology Review, September 2018, Springer Science + Business Media

    Dr Marco Colizzi

  116. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.

    Article • Experimental and Clinical Psychopharmacology, August 2018, American Psychological Association (APA)

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  117. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure

    Article • European Neuropsychopharmacology, July 2018, Elsevier

    Dr Marco Colizzi

  118. S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS

    Article • Schizophrenia Bulletin, April 2018, Oxford University Press (OUP)

    Dr Marco Colizzi

  119. F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY

    Article • Schizophrenia Bulletin, April 2018, Oxford University Press (OUP)

    Dr Marco Colizzi

  120. S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE

    Article • Schizophrenia Bulletin, April 2018, Oxford University Press (OUP)

    Dr Marco Colizzi

  121. Cannabis and psychosis: what do we know and what should we do?

    Article • The British Journal of Psychiatry, March 2018, Royal College of Psychiatrists

    Dr Marco Colizzi

  122. Do Cannabis Users Develop Tolerance for the Psychoactive Effects of Delta-9-tetrahydrocannabinol? an fMRI Study

    Article • February 2018, Morressier

    Dr Marco Colizzi

  123. Neurocognitive effects of cannabis: Lessons learned from human experimental studies

    Article • January 2018, Elsevier

    Dr Marco Colizzi

  124. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains

    Article • Psychological Medicine, November 2017, Cambridge University Press

    Dr Marco Colizzi, Alvaro Diez

  125. Hyperprolactinaemia in first episode psychosis - A longitudinal assessment

    Article • Schizophrenia Research, November 2017, Elsevier

    Dr Marco Colizzi

  126. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

    Article • Current Addiction Reports, April 2017, Springer Science + Business Media

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  127. Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration

    Article • European Neuropsychopharmacology, March 2017, Elsevier

    Dr Marco Colizzi

  128. A Prediction Modelling and Pattern Detection Approach for the First-Episode Psychosis Associated to Cannabis Use

    Article • December 2016, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Marco Colizzi

  129. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study

    Article • The Lancet Psychiatry, October 2016, Elsevier

    Dr Marco Colizzi

  130. The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review

    Article • August 2016, Dove Medical Press

    Dr Marco Colizzi

  131. Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use

    Article • Cortex, August 2016, Elsevier

    Dr Marco Colizzi

  132. To treat or not to treat: puberty suppression in childhood-onset gender dysphoria

    Article • Nature Reviews Urology, July 2016, Nature

    Dr Marco Colizzi

  133. Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence

    Article • Neuroscience & Biobehavioral Reviews, May 2016, Elsevier

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  134. Substance use, medication adherence and outcome one year following a first episode of psychosis

    Article • Schizophrenia Research, February 2016, Elsevier

    Dr Marco Colizzi

  135. Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study

    Article • Schizophrenia, December 2015, Nature

    Dr Marco Colizzi

  136. Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study

    Article • Journal of Psychosomatic Research, April 2015, Elsevier

    Dr Marco Colizzi

  137. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis

    Article • Schizophrenia Bulletin, March 2015, Oxford University Press (OUP)

    Dr Marco Colizzi

  138. Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real?

    Article • Psychiatry Research, March 2015, Elsevier

    Dr Marco Colizzi

  139. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria

    Article • The Journal of Sexual Medicine, January 2015, Elsevier

    Dr Marco Colizzi

  140. Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior

    Article • Neuropsychopharmacology, August 2014, Nature

    Dr Marco Colizzi

  141. Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Marco Colizzi

  142. Attachment Styles in Transsexual Patients and Clinical and Nonclinical Control Groups: A Response

    Article • The Journal of Sexual Medicine, April 2014, Elsevier

    Dr Marco Colizzi

  143. Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study

    Article • Psychoneuroendocrinology, January 2014, Elsevier

    Dr Marco Colizzi

  144. Hormonal Treatment Reduces Psychobiological Distress in Gender Identity Disorder, Independently of the Attachment Style

    Article • The Journal of Sexual Medicine, December 2013, Elsevier

    Dr Marco Colizzi

  145. Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Marco Colizzi

  146. Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Marco Colizzi

  147. COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2010, Elsevier

    Dr Marco Colizzi